Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
We created ChinaBio® Today to give our clients and readers the "inside" business analysis they need to develop successful business and investment strategies in the China life science industry. Our senior editor Dr. Richard Daverman, has over 25 years of editing and reporting experience in biotechnology. Our team of researchers based in Shanghai supports our efforts by identifying news in China first hand that other US publications do not have access to.
Our deep industry experience combined with the day-to-day involvement with domestic and multinational companies and executives doing business in China puts ChinaBio® Today in a unique position to understand the driving factors and events in China's life science industry.
Greg B. Scott – Founding Executive Editor, ChinaBio® Today
Founder, ChinaBio® Group
Mr. Scott leads the investment and consulting activities of ChinaBio® Group (www.chinabio.com) and previously provided the editorial direction for ChinaBio® Today. He is also the co-founder of two private equity investment group that have funded over 45 companies in the US and China. Mr. Scott previously held senior positions in the management consulting practices of Price Waterhouse, Capgemini and MCI, and was a co-founder of a 200-person consulting firm in Silicon Valley. Mr. Scott lives in Zhangjiang Hi-Tech Park in Shanghai, considered by many to be the center of the pharma industry in China.
Richard Daverman, PhD – Business Editor, ChinaBio® Today
Dr. Daverman brings a unique combination of investment management and publishing experience to ChinaBio® Today and develops much of our content. Dr. Daverman has been an editor and author for business and scientific publications including BIOMASS, Business Tennessee, AtTheClose.com, and Execucom. He also brings many years of experience as a financial manager and stockbroker for Prudential-Bache and Robert Thomas Securities. Dr. Daverman received his PhD from University of Michigan and also served on the faculty of Texas A&M University and Universite d'Angers (France).
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Multinational pharma held to a higher standard in China